Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with cisplatin-refractory germ cell tumor: Preliminary experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 5, 2004, Pages 457-460

  De Giorgi, Ugo ^a   Rosti, Giovanni ^a   Papiani, Giorgio ^a   Aieta, Michele ^b   Fochessati, Francesca ^c   Paoluzzi, Luca ^d   Valduga, Francesco ^e   Marangolo, Maurizio ^a  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c OSPEDALE DEGLI INFERMI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Cisplatin refractory germ cell tumor; Gemcitabine; Oxaliplatin; Paclitaxel

Indexed keywords

CARBOPLATIN; CIMETIDINE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; ORPHENADRINE; OXALIPLATIN; PACLITAXEL; VINBLASTINE;

ADULT; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; GERM CELL TUMOR; HUMAN; MALE; NEUROTOXICITY; NEUTROPENIA; PROGNOSIS; SENSORY NEUROPATHY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FEMALE; GERMINOMA; HUMANS; MALE; MEDIASTINAL NEOPLASMS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PACLITAXEL; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 5644273927     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000128727.40450.9e     Document Type: Article

References (17)

1. Loehrer PJ, Gonin R, Nichols CR, et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol. 1998;16:2500-2504.
2. Bokemeyer C, Kollmannsberger C, Harstrick A, et al. Treatment of patients with cisplatin-refractory testicular germ-cell cancer. Int J Cancer. 1999;83:848-851.
3. De Giorgi U, Rosti G, Papiani G, et al. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in patients with germ cell tumor. Haematologica. 2002;87:95-104.
4. Bokemeyer C, Beyer J, Metzner B, et al. Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol. 1996;7:31-34.
5. Sandler AB, Cristou A, Fox S, et al. A phase II trial of paclitaxel in refractory germ cell tumors. Cancer. 1998;82:1381-1386.
6. Einhorn LH, Stender MJ, Williams SD. Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol. 1999;17:509-511.
7. Bokemeyer C, Gerl A, Schoffski P, et al. Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol. 1999;17: 512-516.
8. Kollmannsberger C, Rick O, Derigs HG, et al. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol. 2002;20: 2031-2037.
9. Motzer RJ, Sheinfeld J, Mazumdar M, et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol. 2000;18:2413-2418.
10. de Wit R, Lowerens M, de Mulder PHM, et al. Management of intermediate prognosis germ cell cancer. Results of a phase I-II study of Taxol-BEP. Int J Cancer. 1999;83:831-833.
11. Hinton S, Catalano P, Einhorn LH, et al. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2002;20:1859-1863.
12. Soulié P, Garrino C, Bensmaine MA, et al. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients. J Cancer Res Clin Oncol. 1999;125:707-711.
13. Pizzocaro G, Nicolai N, Salvioni R, et al. Paclitaxel, cisplatin, gemcitabine third line therapy in metastatic germ cell tumors of the testis. Ann Oncol 2002;12(suppl 4):38.
14. Miller AB, Hoodgstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-211.
15. Mavroudis D, Kourousis C, Kakolyris S, et al. Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report. Semin Oncol. 2000;27:25-30.
16. Faivre S, Kalla S, Cvitkovic E, et al. Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: an investigator-originated compassionate-use experience. Ann Oncol. 1999;10: 1125-1128.
17. Jones RH, Vasey PA. New directions in testicular cancer; molecular determinants of oncogenesis and treatment success. Eur J Cancer. 2003;39:147-156.